1316667-72-7Relevant academic research and scientific papers
The 14C, 13C, and 15N syntheses of a potent VEGFR-2 kinase inhibitor, Brivanib, and its prodrug, Brivanib Alaninate
Tran, Scott B.,Lago, Michael W.,Tian, Yuan,Gong, Sharon X.,Batra, Indu,Allentoff, Alban J.,Maxwell, Brad D.,Bonacorsi, Samuel J.,Ogan, Marc,Rinehart, J. Kent,Balasubramanian, Balu
, p. 324 - 331 (2011)
The interruption of tyrosine kinase vascular endothelial growth factor receptor-2 (VEGFR-2) signaling by the binding of a small molecule inhibitor, for example, Brivanib, to VEGFR-2 kinase domain has been shown as an effective method of slowing angiogenes
